Biocon Ltd.

BIOCON

₹361.5

-0.59% (-2.15)

Market Cap

₹43,312 Cr.

P/E

27.40

About

Biocon Limited is an innovation-led global biopharmaceuticals company that manufactures biotechnology products and research services. It focuses on enhancing affordable access to therapies for chronic… Read more

Biocon Limited is an innovation-led global biopharmaceuticals company that manufactures biotec… Read more

Low

218

52W Range

High

396

Quick View

CHART MODE

Price

CHART MODE

EV/EBITDA

Price to Sales

Price to Book

CHART MODE

Capex

CHART MODE

Debt

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

9 Yes

Positive for this company

1 Neutral

Neutral for this company

7 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

1.52 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

0.27 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

4.21 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

1.04 %

(as of Nov 21)

Historic

Blood Related - Market Share

27 %

(as of Mar 19)

Source/Historic

CANMAb - Market Share

0.05 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

0.16 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.04 %

(as of Apr 20)

Historic

Endocrinology - Market Share

0.01 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

75 %

(as of Mar 19)

Source/Historic

Insugen - Market Share

50 %

(as of Mar 19)

Source/Historic

Orlistat API - Market Share

0.01 %

(as of Nov 21)

Historic

Pain - Market Share

21 %

(as of Mar 19)

Source/Historic

Pegfi Igrastim Syringes - Market Sharee

0.30 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

30 %

(as of Mar 20)

Source/Historic

Trastuzumab - Market Share

0.15 %

(as of Jul 22)

Historic

Vaccines - Market Share

0 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

Domestic Sales Growth - YoY (%)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Brands

CANMAb

Insugen

Suppliers

Sobha Ltd.
Alkyl Amines Chemicals Ltd.
B.L. Kashyap and Sons Ltd.

FAQs on Biocon Ltd. Business

What does Biocon do?

Biocon Limited is a global biopharmaceuticals company focusing on developing and manufacturing innovative biologics, biosimilars, and APIs for chronic conditions. They also have a pipeline of novel assets in immunotherapy.

Who are the competitors of Biocon?

Biocon major competitors are Concord Biotech, Advanced Enzyme, Fermenta Biotech, Glaxosmithkline Phar, Ajanta Pharma, Glenmark Pharma, Ipca Laboratories.
Market Cap of Biocon is ₹45,479 Crs.
While the median market cap of its peers are ₹37,452 Crs.

Is Biocon financially stable compared to its competitors?

Biocon seems to be less financially stable compared to its competitors.
Altman Z score of Biocon is 1.53 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call	Mar Jun Sep	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call SummaryCon Call Summary Powered by OpenAI	Sep			Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec